title: Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015.
authors.affiliation: Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Allergy Partners of Central Indiana, Indianapolis, Indiana. Electronic address: epsteite@uc.edu.
authors.forename: Tolly G
authors.initials: TG
authors.lastname: Epstein
authors.affiliation: University of Toronto, Toronto, Ontario, Canada.
authors.forename: Gary M
authors.initials: GM
authors.lastname: Liss
authors.affiliation: Bernstein Clinical Research Center, Cincinnati, Ohio.
authors.forename: Karen
authors.initials: K
authors.lastname: Murphy-Berendts
authors.affiliation: Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Bernstein Clinical Research Center, Cincinnati, Ohio.
authors.forename: David I
authors.initials: DI
authors.lastname: Bernstein
mesh_terms: D000485:Allergens / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods; D004339:Drug Compounding / Q000592:standards*; D004340:Drug Contamination / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D007239:Infections / Q000453:epidemiology* / Q000209:etiology*; D007279:Injections, Subcutaneous
chemical_list: D000485:Allergens